| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4346 | 2018 |
| Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment Q Wang, B Hu, X Hu, H Kim, M Squatrito, L Scarpace, AC DeCarvalho, ... Cancer cell 32 (1), 42-56. e6, 2017 | 1453 | 2017 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 819 | 2016 |
| Epigenomic alterations define lethal CIMP-positive ependymomas of infancy SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ... Nature 506 (7489), 445-450, 2014 | 629 | 2014 |
| VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex KV Lu, JP Chang, CA Parachoniak, MM Pandika, MK Aghi, D Meyronet, ... Cancer cell 22 (1), 21-35, 2012 | 590 | 2012 |
| Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study N Butowski, H Colman, JF De Groot, AM Omuro, L Nayak, PY Wen, ... Neuro-oncology 18 (4), 557-564, 2015 | 506 | 2015 |
| Diffuse midline gliomas with histone H3‐K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations DA Solomon, MD Wood, T Tihan, AW Bollen, N Gupta, JJJ Phillips, ... Brain pathology 26 (5), 569-580, 2016 | 406 | 2016 |
| Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed … AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ... JAMA oncology 6 (4), 495-503, 2020 | 396 | 2020 |
| Pediatric high-grade glioma: biologically and clinically in need of new thinking C Jones, MA Karajannis, DTW Jones, MW Kieran, M Monje, SJ Baker, ... Neuro-oncology 19 (2), 153-161, 2017 | 370 | 2017 |
| Cytogenetic prognostication within medulloblastoma subgroups DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ... Journal of clinical oncology 32 (9), 886, 2014 | 356 | 2014 |
| Tissue mechanics promote IDH1-dependent HIF1α–tenascin C feedback to regulate glioblastoma aggression YA Miroshnikova, JK Mouw, JM Barnes, MW Pickup, JN Lakins, Y Kim, ... Nature cell biology 18 (12), 1336-1345, 2016 | 319 | 2016 |
| A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study A Banerjee, RI Jakacki, A Onar-Thomas, S Wu, T Nicolaides, ... Neuro-oncology 19 (8), 1135-1144, 2017 | 298 | 2017 |
| Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression LE Littlepage, MD Sternlicht, N Rougier, J Phillips, E Gallo, Y Yu, ... Cancer research 70 (6), 2224-2234, 2010 | 273 | 2010 |
| MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism P Bandopadhayay, LA Ramkissoon, P Jain, G Bergthold, J Wala, R Zeid, ... Nature genetics 48 (3), 273-282, 2016 | 267 | 2016 |
| DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors T Mazor, A Pankov, BE Johnson, C Hong, EG Hamilton, RJA Bell, ... Cancer cell 28 (3), 307-317, 2015 | 264 | 2015 |
| Asymmetry-defective oligodendrocyte progenitors are glioma precursors S Sugiarto, AI Persson, EG Munoz, M Waldhuber, C Lamagna, N Andor, ... Cancer cell 20 (3), 328-340, 2011 | 256 | 2011 |
| Toward precision medicine in glioblastoma: the promise and the challenges MD Prados, SA Byron, NL Tran, JJ Phillips, AM Molinaro, KL Ligon, ... Neuro-oncology 17 (8), 1051-1063, 2015 | 245 | 2015 |
| Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth B Hu, Q Wang, YA Wang, S Hua, CEG Sauvé, D Ong, ZD Lan, Q Chang, ... Cell 167 (5), 1281-1295. e18, 2016 | 242 | 2016 |
| Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC FJ Swartling, V Savov, AI Persson, J Chen, CS Hackett, PA Northcott, ... Cancer cell 21 (5), 601-613, 2012 | 237 | 2012 |
| Frequent truncating mutations of STAG2 in bladder cancer DA Solomon, JS Kim, J Bondaruk, SF Shariat, ZF Wang, AG Elkahloun, ... Nature genetics 45 (12), 1428-1430, 2013 | 235 | 2013 |
